on 06 Oct 2020
Last Applicant/ Owned by
CH-4123 Allschwil
Serial Number
79274313 filed on 05th Nov 2019
Registration Number
6166353 registered on 06th Oct 2020
Correspondent Address
Mary Margaret L. O'Donnell
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and dis Read More
Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer
N/A
N/A
No 79274313
No Service/Collective Mark
No SCFE0367WOUS
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
16th Aug 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
14th Feb 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
23rd Jan 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
23rd Jan 2021 | FINAL DISPOSITION PROCESSED |
06th Jan 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
11th Dec 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
06th Oct 2020 | REGISTERED-PRINCIPAL REGISTER |
31st Jul 2020 | NOTIFICATION PROCESSED BY IB |
21st Jul 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
21st Jul 2020 | PUBLISHED FOR OPPOSITION |